alpha1PI

(redirected from a1PI)
Also found in: Acronyms.

α1PI

References in periodicals archive ?
A1PI is intended only for AAT deficient patients who have begun to show symptoms of emphysema.
1 million in higher sales and marketing expenses largely due to the sales force expansion and increased marketing activities for the Gamunex IGIV CIDP indication and for Prolastin A1PI patient identification, $14.
FDA approval for its next generation A1PI product, Prolastin-C.
2 million reduction in Prolastin A1PI revenue mainly as a result of foreign exchange losses of $8.
6 million associated with the terminated CSL merger, higher sales and marketing expenses resulting from the expansion of the sales force and marketing activities for the Gamunex IGIV CIDP and Prolastin A1PI patient identification as well as increased R&D spending.
Aralast(TM) is the second in a class of therapies that serves to treat individuals with alpha-1 proteinase inhibitor deficiency or A1PI.